Development and Internal Validation of a Novel Nomogram Predicting the Outcome of Salvage Radiation Therapy for Biochemical Recurrence after Radical Prostatectomy in Patients without Metastases on Restaging Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography

Development and Internal Validation of a Novel Nomogram Predicting the Outcome of Salvage Radiation Therapy for Biochemical Recurrence after Radical Prostatectomy in Patients without Metastases on Restaging Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography

Background and objective: Owing to the greater use of prostate-specific membrane antigen (PSMA) positron emission tomography/computed tomography (PET/CT) in patients with biochemical recurrence (BCR) of prostate cancer (PCa) after robot-assisted radical prostatectomy (RARP), patient selection for lo...

Full description

Bibliographic Details
Main Authors: Dennie Meijer, Pim J. van Leeuwen, Wietse S.C. Eppinga, Ben G.L. Vanneste, Philip Meijnen, Laurien A. Daniels, Roderick C.N. van den Bergh, Anne P. Lont, Yves J.L. Bodar, Rosemarijn H. Ettema, Katelijne C.C. de Bie, Frederik H.K. Oudshoorn, Jakko A. Nieuwenhuijzen, Henk G. van der Poel, Maarten L. Donswijk, Martijn W. Heymans, Daniela E. Oprea-Lager, Eva E. Schaake, André N. Vis
Format: Article
Language:English
Published: Elsevier 2024-03-01
Series:European Urology Open Science
Subjects:
Salvage radiation therapy
Prostate cancer
Prostate-specific membrane antigen imaging
Positron emission tomography/computed tomography
Nomograms
Online Access:http://www.sciencedirect.com/science/article/pii/S2666168324002192

Internet

http://www.sciencedirect.com/science/article/pii/S2666168324002192

Similar Items